http://www.sciencedaily.com/releases/2012/03/120302101539.htm
ScienceDaily (Mar. 2, 2012) — Cases in which a newly approved drug is more effective than the cheaper alternatives already available are the exceptions rather than the rule.
This is the conclusion reached in a study by Mariam Ujeyl et al. in the current issue of Deutsches Ärzteblatt International.
[...]
..
No comments:
Post a Comment